PAPER
Synthesis of Alkyl Derivatives of Nicotinamide
3837
Piperidinium 3,5-Dicyano-4-methyl-6-hydroxypyridin-2-olate
(7)
4-Methylpyridine-3,5-dicarbonitrile (10a)
2,6-Dibromo-4-methylpyridine-3, 5-dicarbonitrile (9a; 1.47 g, 4.9
mmol) was dissolved in a 1:1 mixture of EtOH and benzene (50 mL)
in a two-necked round-bottomed flask. Pd/CaCO3 (1 g) was then
added and H2 was bubbled through the reaction mixture. The mix-
ture was slowly stirred and maintained under H2 atmosphere, the
product formation was monitored by means of silica gel TLC
(EtOAc–CHCl3, 6:4 v/v). After 3 days, the catalyst was removed by
filtration and the solvent evaporated under reduced pressure. The
remaining thick oil was treated with sat. aq NaHCO3 (15 mL) and
the obtained suspension was extracted with CHCl3 (3 × 20 mL). The
combined organic layers were dried (Na2SO4) and evaporated under
reduced pressure to give a yellow solid that was purified on silica
gel column chromatography (EtOAc–CHCl3, 6:4 v/v) to afford pure
10a (0.51 g, 3.6 mmol, 73%); mp 80–82 °C (Lit.5 mp 84–85 °C).
A mixture of cyanoacetamide (5.98 g, 71.0 mmol), piperidine
(12.17 g, 143.0 mmol) and MeOH (45 mL) was heated until com-
plete dissolution. The obtained solution was cooled to r.t. and acet-
aldehyde (1.56 g, 35.50 mmol) was then added, maintaining the
mixture for 24 h under vigorous stirring. The volume of the ob-
tained suspension was halved under reduced pressure and the white
precipitate was collected, washed with EtOAc (3 × 10 mL), and
dried under reduced pressure to give pure 7 (6.49 g, 24.9 mmol,
70%); mp 245–247 °C.
IR (neat): 3143, 2197, 1655 cm–1.
1H NMR (DMSO-d6): d = 3.00 (m, 4 H, 2 CH2), 2.17 (s, 3 H, CH3),
1.63 (m, 4 H, 2 CH2), 1.55 (m, 2 H, CH2).
13C NMR (DMSO-d6): d = 163.7, 159.9, 119.3, 82.4, 44.29, 22.71,
22.09, 19.9.
IR (neat): 3076, 2193, 1632 cm–1.
1H NMR (DMSO-d6): d = 9.05 (s, 2 H, H-2,6), 2.62 (s, 3 H, CH3).
13C NMR (DMSO-d6): d = 156.4, 155.6, 115.8, 111.8, 20.1.
Anal. Calcd for C13H16N4O2: C, 59.99; H, 6.20; N, 21.52. Found: C,
59.53; H, 6.07; N, 20.37.
Anal. Calcd for C8H5N3: C, 67.12; H, 3.52; N, 29.35. Found: C,
67.41; H, 3.46; N, 29.15.
Ammonium 3,5-Dicyano-4-ethyl-6-hydroxypyridin-2-olate (8)
This compound was prepared according to the procedure described
by Lukes and Kuthan.4 Cyanocetamide (6.02 g, 71.4 mmol) was
suspended in H2O (40 mL), then 25% aq NH3 (2 mL) and propional-
dehyde (2.14 g, 37.0 mmol) were added. The mixture was stirred for
20 h at r.t. The obtained white precipitate was collected by filtration,
washed with small portions of cold MeOH, and dried under reduced
pressure to give pure 8 (5.34 g, 25.9 mmol, 70%); mp >300 °C.
IR (neat): 3165, 2210, 1666 cm–1.
1H NMR (DMSO-d6): d = 2.45 (q, J = 7.6 Hz, 2 H, CH2), 1.13 (t,
J = 7.6 Hz, 3 H, CH3).
4-Ethyl-1,2-dihydropyridine-3,5-dicarbonitrile (10b)
Product 10b (0.41 g, 2.6 mmol, 67%) was prepared from 9b (1.23
g, 3.9 mmol) following the same procedure as described for 10a;
mp 155–160 °C (Lit.6 mp 182–187 °C).
IR (neat): 3313, 2250, 1633 cm–1.
1H NMR (DMSO-d6): d = 8.38 (br s, 1 H, NH), 7.55 (s, 1 H, H-6),
4.10 (s, 2 H, H-2 + H-2¢), 2.30 (q, J = 7.5 Hz, 2 H, CH2), 1.08 (t,
J = 7.5 Hz, 3 H, CH3).
13C NMR (DMSO-d6): d = 153.2, 152.9, 118.1, 115.1, 83.6, 77.6,
41.7, 27.1, 13.4.
13C NMR (DMSO-d6): d = 165.9, 164.2, 118.9, 81.3, 27.4, 14.0.
Anal. Calcd for C9H10N4O2: C, 52.42; H, 4.89; N, 27.17. Found: C,
51.97; H, 5.06; N, 26.85.
Anal. Calcd for C9H9N3: C, 67.90; H, 5.70; N, 26.40. Found: C,
66.46; H, 6.23; N, 26.01.
2,6-Dibromo-4-methylpyridine-3,5-dicarbonitrile (9a)
A mixture of 7 (2.00 g, 7.7 mmol) and POBr3 (4.41 g, 15.4 mmol)
was carefully heated in a sand bath at 170 °C and maintained under
stirring at this temperature for 1 h. After cooling to r.t., the reaction
was quenched by the addition of ice and the obtained suspension
was extracted with CHCl3 (5 × 50 mL). The combined organic ex-
tracts were collected, dried (Na2SO4), and evaporated under vacuum
to give a crude residue from which pure 9a (1.96 g, 6.50 mmol,
84%) was obtained by silica gel column chromatography (eluent:
CHCl3); mp 152–155 °C.
4-Methylpyridine-3,5-dicarboxamide (11a)
Product 11a (0.36 g, 2.0 mmol, 77%) was obtained from 10a (0.37
g, 2.6 mmol) using the same procedure as described for 6;
mp 240 °C.
IR (neat): 3340, 3188, 1660, 1573 cm–1.
1H NMR (DMSO-d6): d = 8.51 (s, 2 H, H-2), 8.01 (br s, 2 H, NHa),
7.67 (br s, 2 H, NHb), 2.39 (s, 3 H, CH3).
13C NMR (DMSO-d6): d = 164.9, 153.8, 142.8, 138.0, 17.9.
Anal. Calcd for C8H9N3O2: C, 53.63; H, 5.06; N, 23.45. Found: C,
53.11; H, 5.39; N, 22.85.
IR (neat): 2237, 1543 cm–1.
1H NMR (CDCl3): d = 2.81 (s, 3 H, CH3).
13C NMR (CDCl3): d = 156.8, 146.6, 115.0, 112.4, 21.1.
4-Ethylpyridine-3,5-dicarboxamide (11b)
Product 11b (0.37 g, 1.9 mmol, 95%) was obtained from 10b (0.32
g, 2.0 mmol) using the same procedure as described for 6; mp
>300 °C.
Anal. Calcd for C9H5Br2N3: C, 34.32; H, 1.60; N, 13.34. Found: C,
34.98; H, 1.46; N, 13.92.
IR (neat): 3346, 3185, 1677, 1623 cm–1.
2,6-Dibromo-4-ethylpyridine-3,5-dicarbonitrile (9b)
Product 9b (2.24 g, 7.1 mmol, 73%) was obtained from salt 8 (2.00
g, 9.7 mmol) following the same procedure as described for com-
pound 9a; mp 122–124 °C.
1H NMR (DMSO-d6): d = 8.48 (s, 2 H, H-2), 8.03 (br s, 2 H, NHa),
7.64 (br s, 2 H, NHb), 2.85 (q, J = 7.6 Hz, 2 H, CH2), 1.13 (t, J = 7.6
Hz, 3 H, CH3).
13C NMR (DMSO-d6): d = 169.9, 148.4, 148.3, 133.8, 22.9, 15.8.
IR (neat): 2236, 1539 cm–1.
1H NMR (acetone-d6): d = 3.13 (q, J = 7.8 Hz, 2 H, CH2), 1.38 (t,
J = 7.8 Hz, 3 H, CH3).
Anal. Calcd for C9H11N3O2: C, 55.95; H, 5.74; N, 21.75. Found: C,
55.66; H, 5.96; N, 21.67.
13C NMR (acetone-d6): d = 164.8, 146.8, 114.1, 113.2, 28.7, 13.9.
Acknowledgment
Anal. Calcd for C9H5Br2N3: C, 34.32; H, 1.60; N, 13.34. Found: C,
34.98; H, 1.46; N, 13.92.
This work was financially supported by Sapienza University of
Rome.
Synthesis 2010, No. 22, 3835–3838 © Thieme Stuttgart · New York